Once the pathophysiological data of the diabetes model and renal function were revealed after PPAR-α activation; the next step was to evaluate the expression, localization, and activity of PPAR-α in two nephron segments after clofibrate (100 mg/kg) administration. The gene discussed is PPARA; the disease is diabetes mellitus.